Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of BMP2 versus MTA as a medicament in pulpotomy of primary molars
IRCT2017062434726N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of dibotermin alfa and mineral trioxide aggregate in reversible pulpitis (2 arms), sponsored by Isfahan University of Medical Sciences. Started May 2017; status: completed.
02
Drugs
dibotermin alfamineral trioxide aggregate
03
Conditions
reversible pulpitis
Beyond the preview
Go deeper on IRCT2017062434726N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017062434726N1.